Clinical features of the clinically examined participants with NT-proBNP ≥900 ng/L
| Variables | n=93 |
| Female, n (%) | 49 (53) |
| BMI, median (Q1–Q3) | 24.8 (23.2–27.5) |
| NT-proBNP, median (Q1–Q3) | 1200 (1000–1750) |
| New diagnosis of AF, n (%) | 28 (30) |
| Hypertension, n (%) | 69 (74) |
| Diabetes mellitus, n (%) | 21 (22.6) |
| Vascular disease*, n (%) | 19 (20.4) |
| Previous AMI, n (%) | 11 (11.8) |
| History of ischaemic stroke/TIA | 11 (11.8) |
| Glomerular filtration rate, mL/min, median (Q1–Q3) | 64 (38–74) |
| Glomerular filtration rate <60 mL/min, n (%) | 41 (44) |
*Previous AMI (Acute Myocardial Infarction), CABG (Coronary By-Pass Surgery) or PCI.(Percutanous Coronary Intervention)
AMI, acute myocardial infarctio; BMI, body mass index; CABG, coronary by-pass surgery; NT-proBNP, N-terminal pro-type-B natriuretic peptide; PCI, percutaneous coronary intervention; Q1, first quartile; Q3, third quartile; TIA, transitory ischaemic attack.